Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1999-09-08
2000-12-05
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
51425214, 544283, 544292, A61K 31517, A61K 31395, C07D23972
Patent
active
061567582
ABSTRACT:
Provided are compounds of formula (I) ##STR1## wherein X, Y and Z are independently CH or N; n is 0 or 1; R.sub.1 is selected from OH, alkoxy, aryloxy, aralkyloxy and guanidinyl; R.sub.2 and R.sub.3 are independently selected from H, halogen, amino, hydroxyl, nitro, cyano and carboxyl; R.sub.4 is H, alkyl or acyl; R.sub.5 is selected from H, hydroxyl, halogen, nitro, alkyl, alkoxy, amino, cyclic amino, alkylamino, arylamino and aralkylamino wherein the alkyl, aryl and cyclic moieties are optionally substituted; R.sub.6 and R.sub.7 are independently selected from H, alkyl, alkoxy, halogen and amino; and R.sub.8 and R.sub.9 are independently selected from H, C.sub.1-4 alkyl, alkoxy, acyl, acyloxy, alkoxycarbonyl, hydroxyl, halogen, amino and carboxyl. The compounds have therapeutic or prophylactic use for treating bacterial infection in mammals.
REFERENCES:
Gazit et al., "Tyrphostins IV--Highly Potent Inhibitors of EGF Receptor Kinase. Structure--Activity Relationship Study of 4-Anilidoquinazolines," Bioorg. Med. Chem., 1996, 4(8), 1203-1207.
Kukla et al., "Synthesis and Anti-HIV-1 Activity of 4,5,6,7,-Tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one (TIBO) Derivatives," J. Med. Chem., 1991, 34, 746-715.
Mach et al., ".sup.18 F-Labeled Benzamides for Studying the Dopamine D.sub.2 Receptor with Positron Emission Tomography," J. Med. Chem., 1993, 36, 3707-3720.
Marchbanks, C. et al., "New Fluoroquinolones", Hospital Therapy,1988, 7, 18-19, 23-27, 31, and 34-35.
Miyamoto et al., "Pyridonecarboxylic Acids as Antibacterial Agents. VIII. An Alternative Synthesis of Enoxacin via Fluoronicotinic Acid Derivatives," Chem. Pharm. Bull., 1987, 35, 2280-2285.
Parry, M., "Pharmacology and Clinical Uses of Quinolone Antibiotics", Medical Times, 1988, 116(12), 39-45 and 19.
Shah, P., "Quinolones", Prog. Drug Res., 1987, 31, 243-256.
Wagaw et al., "The Synthesis o Aminopyridines: A Method Employing Palladium-Catalyzed Carbon-Nitrogen Bond Formation," J. Org. Chem., 1996, 61, 7240-7241.
Wolfe et al, "An Improved Catalyst System for Aromatic Carbon-Nitrogen Bond Formation: The Possible Involvement of Bis(Phosphine) Palladium Complexes as Key Intermediates," J. Am. Chem. Soc., 1996, 118, 7215-7216.
Cook Phillip Dan
Guinosso Charles John
Kung Pei-Pei
ISIS Pharmaceuticals Inc.
Patel Sudhaker B.
Shah Mukund J.
LandOfFree
Antibacterial quinazoline compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibacterial quinazoline compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibacterial quinazoline compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-962003